A study to assess the clinical characteristics and mortality rates of bloodstream infections by Kpc-Producing Klebsiella Pneumoniae in Neutropenic Patients with Acute Myeloid Leukemia treated with Ceftazidime-Avibactam
Latest Information Update: 22 Jul 2020
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Klebsiella infections
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association